Mercury Pharmaceuticals

We are de-risking biomedical innovations, while turning biomedical knowledge into social and economic value.

Stay Informed!

Survey: Many Americans unaware of diet's impact on cholesterol

8

Jun 2026

Survey: Many Americans unaware of diet's impact on cholesterol

On the heels of updated cholesterol management guidance that recommends earlier screening and establishes target goals for LDL "bad" cholesterol based on an individual's risk factors, a new Physicians Committee for Responsible Medicine/Morning Consult survey finds that one in five U.S. adults is unaware that what they eat directly affects blood cholesterol levels.

Medicare insulin cap lowers out-of-pocket costs and boosts usage

8

Jun 2026

Medicare insulin cap lowers out-of-pocket costs and boosts usage

The Inflation Reduction Act's attempt to improve insulin costs for Medicare beneficiaries-by capping out-of-pocket costs at $35-was associated with lower out-of-pocket costs and increased insulin usage, but only for a small portion of U.S. patients, according to a new study published in JAMA on Saturday.

New project launches to advance chikungunya vaccine in Africa

8

Jun 2026

New project launches to advance chikungunya vaccine in Africa

Funded by the Global Health EDCTP3 Joint Undertaking, a new €15.3 million project coordinated by Institut Pasteur brings together seven partners across four continents to advance clinical trials and prepare for the manufacturing of a chikungunya vaccine in Africa.

Extreme temperatures pose growing danger to heart health

8

Jun 2026

Extreme temperatures pose growing danger to heart health

Extreme heat and cold are growing cardiovascular risks that can trigger heart attacks, strokes, heart failure and sudden cardiac death, according to a recent scientific statement by experts at Weill Cornell Medicine and other leading institutions.

MERCURY trials

Clinical trials are very important as it allow us to evaluate the effectiveness of new drugs, new devices, preventative strategies or treatment strategies. It also enables us to discover better ways for patients' care.
- Learn more

Cancer

Our mission remains constant as we endeavor to deliver novel medicines to patients with cancer, treating solid tumors with high unmet medical needs in well-defined patient populations that are currently not well supported.
- Learn more

Neuroscience

Whether you're looking to manufacture toxicology batches or cGMP material for clinical trials, we can help you expedite molecules to clinic with full transparency.
- Learn more

Mercury Pharmaceuticals

Why Us?

Strong experience in academic research and technology transfer makes us understand your goals and motivations as a technology originator.
Our experience in drug development from discovery to clinical and commercial stages makes us an insider player within the biopharmaceutical industry.
Smart approach to project management that helps speed up development stages and decision making.
Availability of own investment up to 2m€ per project allows us to reach the next value milestone.